Bionano Genomics, Inc.
USD1.13
-0.04 (-3.42%)
CEO
Robert Erik Holmlin
IPO Date
2018-08-21
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$1.18
Prev. Close
$1.17
Day Low
$1.13
Day High
$1.18
52W Low
$1.06
52W High
$5.50
Market Cap
$0.01B
Volume
0.24M
| -0.3 |
| 31 Dec 2023 | FY | 26.5% | -643.7% | -241.8% | -108.4% | 0.83 | 1.40 | -0.3 |
| 31 Dec 2022 | FY | 21.4% | -476.9% | -53.2% | -43.1% | 0.05 | 4.38 | -3.2 |
| 31 Dec 2021 | FY | 21.5% | -402.8% | -21.5% | -19.2% | 0.03 | 12.47 | -11.7 |
| 31 Dec 2020 | FY | 32.6% | -483.4% | -117.2% | -68.0% | 0.47 | 5.23 | -8.0 |
| 31 Dec 2019 | FY | 33.2% | -294.3% | -825.1% | -98.7% | 5.56 | 1.07 | -0.0 |
| 31 Dec 2018 | FY | 27.4% | -154.1% | -182.5% | -74.6% | 0.89 | 5.09 | -0.0 |
| 31 Dec 2017 | FY | 36.6% | -245.8% | 46.5% | -230.3% | -0.13 | 0.43 | 0.0 |
| 31 Dec 2016 | FY | 47.3% | -277.5% | 69.1% | -127.5% | -0.24 | 1.15 | 0.0 |
| -0.3 |
| 30 Sept 2025 | Q3 | 45.7% | -115.4% | -17.1% | -10.8% | 0.15 | 2.12 | -0.3 |
| 30 Jun 2025 | Q2 | 51.6% | -101.8% | -15.1% | -9.0% | 0.43 | 1.76 | -0.4 |
| 31 Mar 2025 | Q1 | 45.5% | -48.0% | -6.4% | -4.0% | 0.38 | 1.70 | -0.6 |
| 31 Dec 2024 | Q4 | 41.9% | -246.5% | -56.9% | -26.2% | 0.77 | 1.06 | -0.4 |
| 30 Sept 2024 | Q3 | -139.1% | -728.6% | -90.5% | -50.6% | 0.46 | 1.43 | -0.2 |
| 30 Jun 2024 | Q2 | 33.3% | -208.8% | -20.2% | -12.5% | 0.34 | 1.63 | -0.7 |
| 31 Mar 2024 | Q1 | 32.2% | -358.3% | -38.0% | -19.9% | 0.46 | 1.46 | -0.5 |
| 31 Dec 2023 | Q4 | 22.7% | -409.4% | -45.6% | -20.5% | 0.83 | 1.40 | -0.4 |